Frequency Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview

Korro Bio

11/08/2021 03:38

* Frequency Therapeutics Inc  FREQ.OQ   FREQ.O  is expected
to show a fall in quarterly revenue when it reports results on
August 11 (estimated). 
* The Woburn, Massachusetts-based company is expected to report 
 a 21.3% decrease in revenue to $6.709 million from $8.52
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Frequency Therapeutics
Inc is for a loss of 51 cents per share. For the same quarter
last year, the company reported a loss of 19 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $15​, about 45.3% above​ its last closing
price of $8.21. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.28       -0.28      -0.60     Missed  -116.9
 Dec. 31 2020  -0.26       -0.25      -0.30     Missed  -17.8
 Sep. 30 2020  -0.27       -0.28      -0.16     Beat    42.6​
 Jun. 30 2020  -0.19       -0.18      -0.19     Missed  -3.1
 Mar.          -0.18​      -0.17      -0.16     Beat    7.5​
 31​ 2020​                                              
 Dec. 31 2019              0.10       -0.19     Missed  -287.2
                                                        ​
 Sep. 30 2019  -0.68       -0.68      -0.73     Missed  -7.4
 This summary was machine generated August 11 at 02:38 GMT.  All
figures in US dollars unless otherwise stated